|4Feb 22, 5:28 PM ET

Kellen Scott 4

4 · Sun BioPharma, Inc. · Filed Feb 22, 2018

Insider Transaction Report

Form 4
Period: 2018-02-20
Kellen Scott
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2018-02-20+1,0004,500 total
  • Purchase

    Warrant (right to buy)

    2018-02-20+1,0001,000 total
    Exercise: $5.00From: 2018-02-20Exp: 2021-02-20Common Stock (1,000 underlying)
Footnotes (1)
  • [F1]Reported securities purchased as one share of common stock and one warrant to purchase one share of common stock for a combined price of $5.00 per "unit."

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    KELLEN FORM 4 2-20-18